{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:02:14Z","timestamp":1783465334180,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ejca.2014.10.017","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T05:42:25Z","timestamp":1415252545000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Differential proteomic analysis of endemic and sporadic Epstein\u2013Barr virus-positive and negative Burkitt lymphoma"],"prefix":"10.1016","volume":"51","author":[{"given":"Nader Kim","family":"El-Mallawany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Ayello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmella","family":"Van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Fermin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0853-9655","authenticated-orcid":false,"given":"Venkatesha","family":"Basrur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojo","family":"Elenitoba-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S.","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2014.10.017_b0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/asheducation-2007.1.277","article-title":"Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy","author":"Kelly","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ejca.2014.10.017_b0010","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt\u2019s lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2014.10.017_b0015","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2014.10.017_b0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1532","article-title":"Reverse engineering of regulatory networks in human B cells","volume":"37","author":"Basso","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2014.10.017_b0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1044-579X(02)00058-5","article-title":"Role of genetic and epigenetic changes in Burkitt lymphoma","volume":"12","author":"Lindstrom","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ejca.2014.10.017_b0030","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1182\/blood-2010-08-301556","article-title":"Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes","volume":"117","author":"Piccaluga","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2014.10.017_b0035","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood.V77.7.1516.1516","article-title":"Patterns of chromosomal breakpoint locations in Burkitt\u2019s lymphoma: relevance to geography and Epstein\u2013Barr virus association","volume":"77","author":"Shiramizu","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2014.10.017_b0040","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.4049\/jimmunol.175.5.2968","article-title":"EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis","volume":"175","author":"Clybouw","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ejca.2014.10.017_b0045","doi-asserted-by":"crossref","first-page":"14935","DOI":"10.1073\/pnas.0509988103","article-title":"Three restricted forms of Epstein\u2013Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells","volume":"103","author":"Kelly","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2014.10.017_b0050","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1128\/JVI.79.16.10709-10717.2005","article-title":"Epstein\u2013Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt\u2019s lymphoma cells and with increased resistance to apoptosis","volume":"79","author":"Kelly","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.ejca.2014.10.017_b0055","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","article-title":"Epstein\u2013Barr virus provides a survival factor to Burkitt\u2019s lymphomas","volume":"100","author":"Kennedy","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2014.10.017_b0060","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","article-title":"Oncogenic role of Epstein\u2013Barr virus-encoded RNAs in Burkitt\u2019s lymphoma cell line Akata","volume":"73","author":"Komano","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.ejca.2014.10.017_b0065","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/emboj\/21.5.954","article-title":"Epstein\u2013Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt\u2019s lymphoma","volume":"21","author":"Nanbo","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.ejca.2014.10.017_b0070","doi-asserted-by":"crossref","first-page":"10223","DOI":"10.1128\/JVI.74.21.10223-10228.2000","article-title":"Epstein\u2013Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis","volume":"74","author":"Ruf","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.ejca.2014.10.017_b0075","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.4049\/jimmunol.177.5.3035","article-title":"Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator","volume":"177","author":"Donati","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ejca.2014.10.017_b0080","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(04)01650-X","article-title":"Is endemic Burkitt\u2019s lymphoma an alliance between three infections and a tumour promoter?","volume":"5","author":"van den Bosch","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2014.10.017_b0085","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/leu.2011.156","article-title":"The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma","volume":"25","author":"Lenze","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2014.10.017_b0090","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/blood-2009-02-204735","article-title":"The proteomic signature of NPM\/ALK reveals deregulation of multiple cellular pathways","volume":"114","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2014.10.017_b0095","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/labinvest.3700167","article-title":"Proteomics in pathology research","volume":"84","author":"Lim","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejca.2014.10.017_b0100","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/pmic.200700108","article-title":"Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells","volume":"7","author":"Schumacher","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.ejca.2014.10.017_b0105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jprot.2011.01.017","article-title":"Proteome profiling of Epstein\u2013Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC\/MS\u2013MS analysis","volume":"74","author":"Feng","year":"2011","journal-title":"J Proteomics"},{"key":"10.1016\/j.ejca.2014.10.017_b0110","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/bioinformatics\/bth092","article-title":"TANDEM: matching proteins with tandem mass spectra","volume":"20","author":"Craig","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejca.2014.10.017_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1198\/016214506000001211","article-title":"Correlation and large-scale simultaneous significance testing","volume":"102","author":"Efron","year":"2007","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ejca.2014.10.017_b0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V116.21.631.631","article-title":"Comparative genomic identification of unique signal transduction pathways and targets in pediatric Burkitt lymphoma (PBL)","volume":"116","author":"Day","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2014.10.017_b0125","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ygeno.2005.08.012","article-title":"The HSP90 family of genes in the human genome: insights into their divergence and evolution","volume":"86","author":"Chen","year":"2005","journal-title":"Genomics"},{"key":"10.1016\/j.ejca.2014.10.017_b0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-5793(00)01494-0","article-title":"ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1)","volume":"473","author":"Feo","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ejca.2014.10.017_b0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1073\/pnas.0404852102","article-title":"CD98hc (SLC3A2) mediates integrin signaling","volume":"102","author":"Feral","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2014.10.017_b0140","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/embo-reports\/kvf236","article-title":"RIP4 (DIK\/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis","volume":"3","author":"Meylan","year":"2002","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ejca.2014.10.017_b0145","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2005-10-4285","article-title":"Monocyte-derived CXCL7 peptides in the marrow microenvironment","volume":"107","author":"Pillai","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2014.10.017_b0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jcp.47.1.9","article-title":"P53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin\u2019s lymphomas","volume":"47","author":"Korkolopoulou","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejca.2014.10.017_b0155","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1016\/S0021-9258(19)78087-9","article-title":"D-type cyclin-binding regions of proliferating cell nuclear antigen","volume":"269","author":"Matsuoka","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2014.10.017_b0160","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2014.10.017_b0165","first-page":"2508","article-title":"Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt\u2019s lymphoma cells","volume":"57","author":"Cherney","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2014.10.017_b0170","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/sj.onc.1201702","article-title":"Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt\u2019s lymphoma cells","volume":"16","author":"Capoulade","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2014.10.017_b0175","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/leu.2010.138","article-title":"The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling","volume":"24","author":"Hussain","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2014.10.017_b0180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1535-6108(03)00029-1","article-title":"Heat shock protein 90 as a molecular target for cancer therapeutics","volume":"3","author":"Isaacs","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2014.10.017_b0185","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01913","article-title":"A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors","volume":"425","author":"Kamal","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2014.10.017_b0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/path.2219","article-title":"The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein\u2013Barr virus-positive NK\/T-cell lymphoma by Akt down-regulation","volume":"213","author":"Jeon","year":"2007","journal-title":"J Pathol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914010533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914010533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T11:19:18Z","timestamp":1650539958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804914010533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0959804914010533"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2014.10.017","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential proteomic analysis of endemic and sporadic Epstein\u2013Barr virus-positive and negative Burkitt lymphoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2014.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}